We're awaiting earnings from Pfizer this morning, which is simultaneously trying to acquire U.K. drugmaker AstraZeneca--in a deal that may cost it much more than the $106 billion it already offered. Orbitz is set to report earnings as well--after underperforming competitors Priceline and Tripadvisor, analysts are forecasting a loss. And Jim Cramer is charged up over one pick he's saying could catch fire in emerging markets.

More from Video

10 Seconds to Genius: Lowe's New CEO Marvin Ellison

10 Seconds to Genius: Lowe's New CEO Marvin Ellison

Replay: Jim Cramer on the Markets, Oil, General Electric, Zillow and Micron

Replay: Jim Cramer on the Markets, Oil, General Electric, Zillow and Micron

NYSE's New President: On a Mission to Attract Talent to Wall St.

NYSE's New President: On a Mission to Attract Talent to Wall St.

Pegasystems Founder Explains Why He Has One of the Hottest Tech Stocks Around

Pegasystems Founder Explains Why He Has One of the Hottest Tech Stocks Around

10 Seconds To Genius: Facebook

10 Seconds To Genius: Facebook